ReviewAnnals of medicine and surgery (2012)2025
Elderly coagulation risk in a globalized world: burden, biomarkers, and management in Africa - a narrative review.
Review in Annals of medicine and surgery (2012), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The global increase in life expectancy has brought aging-related health challenges to the forefront, with coagulation disorders emerging as a significant cause of morbidity and mortality among the elderly. In Africa, the burden of coagulation abnormalities is becoming increasingly evident due to demographic shifts, the rising prevalence of noncommunicable diseases, and the persistent impact of infectious diseases that affect coagulation pathways. Despite this growing challenge, limited data and constrained healthcare resources hinder effective recognition and management of these conditions. Biomarkers such as D-dimer, prothrombin time, activated partial thromboplastin time, and platelet indices play a crucial role in diagnosing and monitoring coagulation disorders in elderly patients. However, the availability and utilization of these diagnostic tools remain inconsistent across African healthcare settings, limiting timely risk stratification and intervention. Emerging biomarkers offer potential for improved assessment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.